Insights · Perspective
Building EquiTrack: rethinking institutional access to private markets
Private markets have never been larger — or harder to reach. We are building the infrastructure to change the access model, not just the asset.
20 May 2026 · 4 min read · EquiTrack team
The companies defining the next decade are staying private for longer, and in many cases indefinitely. The growth that public-market investors once accessed through an IPO now compounds behind closed doors — visible to allocators, but structurally out of reach for most of them.
The access routes that do exist were not designed for flexibility. Funds, SPVs and secondaries deliver exposure, but with long lock-ups, high minimums, slow timelines and an operational burden that committees feel every quarter. The asset class is compelling; the access model is the problem.
Change the access model, not just the asset
EquiTrack is being built on a simple thesis: tokenisation is only interesting to institutions if it improves the operating model. Putting an illiquid structure on-chain and calling it innovation solves nothing. What allocators actually need is diversified exposure to private-market themes with transparent reference values, predictable settlement, permissioned access and reporting their oversight functions can consume.
That is the product we are building: curated, rules-based thematic baskets, issued and governed by EquiTrack, settled in USDC, restricted to eligible institutions, and distributed across approved venues rather than locked to a single exchange.
Institution-first is a sequencing decision
We are deliberately institution-first. Professional allocators ask the hardest questions about methodology, custody, risk controls and governance — and answering those questions properly, before launch, produces a stronger product than scaling first and retrofitting discipline later. There is no retail access by design.
We are pre-authorisation, and we describe ourselves that way. What we are building, we will evidence — testnet validation, independent review and licence-gated deployment, in that order.
This article is provided for information only. It is not an offer, an invitation to invest, or advice of any kind. EquiTrack is pre-authorisation: products described are planned and subject to regulatory approval.